Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
Westrock Coffee Company Reports Third Quarter 2024 Results
From Westrock Coffee Company
Via GlobeNewswire
Tickers WEST
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
From Definitive Healthcare Corp.
Via GlobeNewswire
Tickers DH
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
From Lyell Immunopharma, Inc
Via GlobeNewswire
Tickers LYEL
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024
From Robinhood Markets, Inc.
Via GlobeNewswire
Tickers HOOD
Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
From Atea Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers AVIR
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
From CytoSorbents
Via GlobeNewswire
Tickers CTSO
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
ACV Announces Third Quarter 2024 Results
From ACV
Via GlobeNewswire
Tickers ACVA
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Tickers VOR
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
From Myriad Genetics, Inc.
Via GlobeNewswire
Tickers MYGN
Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
From Elicio Therapeutics Inc.
Via GlobeNewswire
Tickers ELTX
Jamf Releases Third Quarter 2024 Financial Results
From Jamf
Via GlobeNewswire
Tickers JAMF
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
From Cibus US LLC
Via GlobeNewswire
Tickers CBUS
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
From Assembly Biosciences, Inc.
Via GlobeNewswire
Tickers ASMB
CarGurus Announces Third Quarter 2024 Results
From CarGurus, Inc.
Via GlobeNewswire
Tickers CARG
TELA Bio Reports Third Quarter 2024 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
SuRo Capital Corp. Reports Third Quarter 2024 Financial Results
From SuRo Capital Corp.
Via GlobeNewswire
Tickers SSSS
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
From NextCure
Via GlobeNewswire
Tickers NXTC
Profound Medical Announces Third Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
From 89bio, Inc.
Via GlobeNewswire
Tickers ETNB
Jushi Holdings Inc. Reports Third Quarter 2024 Financial Results
From Jushi Holdings Inc.
Via GlobeNewswire
Tickers CSE:JUSH JUSHF
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2025 Financial Results
From Nutanix, Inc.
Via GlobeNewswire
Tickers NTNX
Brilliant Earth Reports Third Quarter 2024 Results
From Brilliant Earth, LLC
Via GlobeNewswire
Tickers BRLT
Fortinet Reports Third Quarter 2024 Financial Results
From Fortinet, Inc.
Via GlobeNewswire
Tickers FTNT
Jeff’s’ Brands Initiates Strategic Plan by Entering into a Non-Binding Letter of Intent to Sell Subsidiary to a U.S. Public Company at a valuation of approximately $13.125 million
From Jeffs' Brands Ltd
Via GlobeNewswire
Tickers JFBR JFBRW
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
From Pliant Therapeutics, Inc.
Via GlobeNewswire
Tickers PLRX
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Ceribell
Via GlobeNewswire
Tickers CBLL
U.S. Global Investors Reports Profitability for the First Quarter of 2025 Fiscal Year
From U.S. Global Investors
Via GlobeNewswire
Tickers GROW
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.